Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 4 of 4 clinical reviews.
AndroGel (testosterone gel 1% and 1.62%) can cause side effects that develop weeks to months after starting therapy. This clinician-reviewed guide covers delayed-onset adverse events, their mechanisms, timelines, and what the evidence says about monitoring and management.
Read clinical reviewA clinically detailed review of AndroGel's rare but serious adverse events, covering cardiovascular risk, polycythemia, secondary exposure, hepatotoxicity, and more, with citations to FDA labeling, FAERS, and primary trials.
Read clinical reviewA clinical breakdown of AndroGel (testosterone gel 1% and 1.62%) adverse events by frequency, severity, and patient risk phenotype, with trial data, FAERS analysis, and prescribing guidance.
Read clinical reviewA comprehensive clinical guide to AndroGel (testosterone gel) withdrawal and discontinuation syndrome, including symptoms, timelines, management strategies, and what the evidence says about stopping TRT safely.
Read clinical review